UMB Bank n.a. boosted its stake in Teleflex Incorporated (NYSE:TFX – Free Report) by 3,763.6% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 425 shares of the medical technology company’s stock after buying an additional 414 shares during the quarter. UMB Bank n.a.’s holdings in Teleflex were worth $59,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also made changes to their positions in TFX. MassMutual Private Wealth & Trust FSB boosted its position in Teleflex by 103.1% during the first quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company’s stock worth $27,000 after acquiring an additional 100 shares during the last quarter. Headlands Technologies LLC acquired a new stake in shares of Teleflex in the fourth quarter valued at $29,000. Whipplewood Advisors LLC increased its stake in Teleflex by 7,700.0% during the first quarter. Whipplewood Advisors LLC now owns 234 shares of the medical technology company’s stock worth $32,000 after purchasing an additional 231 shares during the period. True Wealth Design LLC increased its stake in Teleflex by 62.3% during the 4th quarter. True Wealth Design LLC now owns 271 shares of the medical technology company’s stock worth $48,000 after buying an additional 104 shares during the period. Finally, IFP Advisors Inc increased its position in shares of Teleflex by 238.5% during the fourth quarter. IFP Advisors Inc now owns 308 shares of the medical technology company’s stock worth $55,000 after acquiring an additional 217 shares during the period. Hedge funds and other institutional investors own 95.62% of the company’s stock.
Wall Street Analyst Weigh In
Several analysts recently weighed in on the stock. Truist Financial reduced their target price on shares of Teleflex from $140.00 to $137.00 and set a “hold” rating on the stock in a report on Monday, May 5th. Wells Fargo & Company decreased their target price on Teleflex from $146.00 to $137.00 and set an “equal weight” rating for the company in a research report on Friday, May 2nd. Bank of America downgraded shares of Teleflex from a “neutral” rating to an “underperform” rating and lowered their price objective for the stock from $235.00 to $140.00 in a research report on Tuesday, March 4th. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a report on Wednesday, March 12th. Finally, Wall Street Zen cut shares of Teleflex from a “buy” rating to a “hold” rating in a report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $164.63.
Teleflex Stock Performance
Shares of TFX opened at $119.93 on Friday. Teleflex Incorporated has a 12-month low of $118.70 and a 12-month high of $249.91. The stock has a market cap of $5.30 billion, a P/E ratio of 23.84, a PEG ratio of 1.73 and a beta of 1.10. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The company has a 50-day moving average of $126.73 and a two-hundred day moving average of $152.40.
Teleflex (NYSE:TFX – Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.88 by $0.03. The firm had revenue of $700.67 million during the quarter, compared to the consensus estimate of $699.37 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The company’s quarterly revenue was down 5.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $3.21 EPS. As a group, research analysts predict that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.
Teleflex Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Tuesday, May 20th will be paid a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 1.13%. The ex-dividend date of this dividend is Tuesday, May 20th. Teleflex’s payout ratio is 42.90%.
Teleflex Company Profile
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
See Also
- Five stocks we like better than Teleflex
- Top Biotech Stocks: Exploring Innovation Opportunities
- Synopsys Stock Falls on China Ban, But Long-Term Outlook Holds
- Best Stocks Under $5.00
- Alphabet Enters a Bull Market: Is It Time to Buy?
- Investing in Travel Stocks Benefits
- Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for Drones
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.